Glycobiology and Extracellular Matrices
A Novel Mechanism for LSECtin Binding to Ebola Virus Surface Glycoprotein through Truncated Glycans*

https://doi.org/10.1074/jbc.M706292200Get rights and content
Under a Creative Commons license
open access

LSECtin is a member of the C-type lectin family of glycan-binding receptors that is expressed on sinusoidal endothelial cells of the liver and lymph nodes. To compare the sugar and pathogen binding properties of LSECtin with those of related but more extensively characterized receptors, such as DC-SIGN, a soluble fragment of LSECtin consisting of the C-terminal carbohydrate-recognition domain has been expressed in bacteria. A biotin-tagged version of the protein was also generated and complexed with streptavidin to create tetramers. These forms of the carbohydrate-recognition domain were used to probe a glycan array and to characterize binding to oligosaccharide and glycoprotein ligands. LSECtin binds with high selectivity to glycoproteins terminating in GlcNAcβ1-2Man. The inhibition constant for this disaccharide is 3.5 μm, making it one of the best low molecular weight ligands known for any C-type lectin. As a result of the selective binding of this disaccharide unit, the receptor recognizes glycoproteins with a truncated complex and hybrid N-linked glycans on glycoproteins. Glycan analysis of the surface glycoprotein of Ebola virus reveals the presence of such truncated glycans, explaining the ability of LSECtin to facilitate infection by Ebola virus. High mannose glycans are also present on the viral glycoprotein, which explains why DC-SIGN also binds to this virus. Thus, multiple receptors interact with surface glycoproteins of enveloped viruses that bear different types of relatively poorly processed glycans.

Cited by (0)

*

This work was supported in part by Wellcome Trust Grant 041845 (to K. D. and M. E. T.), a grant from the Biotechnology and Biological Sciences Research Council (to A. D.), Deutsche Forschungsgemeinschaft Grant SFB466 (to T. F. and S. P.), and NIGMS, National Institutes of Health Grant GM62116 (to the Consortium for Functional Glycomics). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement”in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1.

1

Funded by the Research Councils United Kingdom Basic Technology Programme (UK GlycoArrays Consortium grant).

2

A Biotechnology and Biological Sciences Research Council Professorial Research Fellow.